Reuters
@Reuters·4.2M subscribers·86.9K videos
Novo Nordisk shares dip after obesity drug price deal | REUTERS
Posted
November 7, 2025
Views
6,844
Likes
39
Engagement
0.57%
November 7, 2025
6,844
39
0.57%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:19Now PlayingShares in Novo Nordisk fell as much as 3% after the Danish drugmaker and US rival Eli Lilly agreed with the US government to lower prices of their blockbuster GLP-1 weight-loss drugs.
#News #Reuters #Newsfeed
Read the story here
👉 Subscribe
Keep up with the latest news from around the world
Follow Reuters on Facebook
Follow Reuters on Twitter
Follow Reuters on Instagram
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
